*Tomorrow’s Barron’s suggests buying not one but two of our existing holdings, both of which I have already partly exited, with profits on one and a loss on the other.
The profits were on Marine Harvest Group (MHG), the Norwegian supplier of cheap protein from salmon fish-farms to the world. It is gaining from an algae outbreak in Chilean waters where smaller rival fish-farms supplying the US market congregate, writes Jonathan Buck. He barely gives the ADR ticker symbol which makes his advice sound far more insightful than it actually is. If MHG pushes up US fish prices too high, it will reduce the already tough sell of farmed salmon, which frankly is not the taste champion at the fish-monger’s.
Barron’s also figured out that retail investors can join the high-net-worth crowd by buying the closed-end fund version of Bill Ackman’s Pershing Square Holdings (PSHZF). We told you first over a year ago and last week I sold half of my stake in PSHZF which is listed in Amsterdam in US$ and trades mostly in London. Now you have an opportunity to sell even higher if the Barron’s readership decide to “buy Ackman on the cheap”, following Andrew Barry.
Actually if you want to play the possibly recovery of Valeant Pharma of Canada now that Ackman has joined its board, you can do so more safely and securely by buying into Canadian General, CGI in Toronto or CGRIF on the US pink sheets. The argument for buying with Vanessa Morgan, CFA, is CGI’s huge 28.27% discount from net-asset value which her family controlled fund has had to contend with for ages (and we have owned it for ages.) It is a lot easier to buy from North America than the Ackman fund. I bought PSH with e-trade and then managed to move it over to my new account with Interactive Brokers, but with both moves I have to claim to be a qualified investor.
The data on closed-end funds is not complete this week because of Good Friday, but CGI provided its net-asset value a day early, something other large fund complexes could not achieve.
